Segall Bryant & Hamill LLC Cuts Stake in AdaptHealth Corp. (NASDAQ:AHCO)

Segall Bryant & Hamill LLC decreased its holdings in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 1.0% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,753,806 shares of the company's stock after selling 50,175 shares during the period. AdaptHealth comprises approximately 0.8% of Segall Bryant & Hamill LLC's investment portfolio, making the stock its 11th biggest holding. Segall Bryant & Hamill LLC owned about 3.52% of AdaptHealth worth $51,531,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of AHCO. SummerHaven Investment Management LLC boosted its position in AdaptHealth by 1.7% during the first quarter. SummerHaven Investment Management LLC now owns 79,883 shares of the company's stock valued at $866,000 after purchasing an additional 1,329 shares in the last quarter. Guggenheim Capital LLC grew its position in shares of AdaptHealth by 10.1% in the 4th quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after buying an additional 1,525 shares during the last quarter. Sterling Capital Management LLC raised its stake in shares of AdaptHealth by 5.2% during the 4th quarter. Sterling Capital Management LLC now owns 33,558 shares of the company's stock worth $319,000 after acquiring an additional 1,644 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in AdaptHealth by 3.6% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 57,931 shares of the company's stock valued at $552,000 after acquiring an additional 1,999 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. boosted its stake in AdaptHealth by 6.8% in the first quarter. Oppenheimer Asset Management Inc. now owns 32,797 shares of the company's stock valued at $356,000 after acquiring an additional 2,081 shares in the last quarter. Institutional investors own 82.67% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Truist Financial decreased their price objective on AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a report on Monday, May 12th. Royal Bank Of Canada decreased their price target on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a research note on Thursday, May 8th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $13.40.

AdaptHealth Stock Performance

Shares of AHCO stock traded up $0.10 during trading hours on Thursday, hitting $9.23. The company's stock had a trading volume of 654,660 shares, compared to its average volume of 1,329,358. The company has a current ratio of 1.29, a quick ratio of 1.07 and a debt-to-equity ratio of 1.25. The company has a 50 day moving average of $8.96 and a 200 day moving average of $9.40. AdaptHealth Corp. has a 12-month low of $7.11 and a 12-month high of $11.90. The stock has a market cap of $1.24 billion, a PE ratio of 16.17, a price-to-earnings-growth ratio of 1.03 and a beta of 1.63.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.